Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Q Hatton

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Thorax|March 1, 1996
Compliance with oral corticosteroids during steroid trials in chronic airways obstructionM Q Hatton, M B Allen, S V Vathenen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 2009
Response on behalf of the UK Stereotactic Body Radiotherapy Consortium to Brock et al. Clin Oncol (R Coll Radiol) 2008;20(9):666-676K N Franks, P Jain, M Dahele, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 3, 2008
Epirubicin/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual functionJ M Zekri, L M El-Helw, O P Purohit, et al.
The British Journal of Radiology|July 23, 2013
Stereotactic ablative radiotherapy in the UK: current status and developmentsP Jain, A Baker, G Distefano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2001
The impact of virtual simulation in palliative radiotherapy for non-small-cell lung cancerM McJury, P M Fisher, S Pledge, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
Carboplatin, 5-fluorouracil and folinic acid: a 48-hour chemotherapy regimen in advanced and recurrent squamous carcinoma of the head and neckM Q Hatton, E J Junor, J Paul, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 11, 2004
The management and survival of patients with advanced germ-cell tumours: improving outcome in intermediate and poor prognosis patientsN Bhala, J M Coleman, C R Radstone, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 24, 2009
Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvementJ D Fenwick, A E Nahum, Z I Malik, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 30, 2010
Review of testing and use of adjuvant trastuzumab across a cancer network--are we treating the right patients?S G Coulson, V S Kumar, I M Manifold, et al.
BMJ Supportive & Palliative Care|May 3, 2014
Quality of life, support and smoking in advanced lung cancer patients: a qualitative studyC Rowland, S J Danson, R Rowe, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Thorax|March 1, 1996
Compliance with oral corticosteroids during steroid trials in chronic airways obstructionM Q Hatton, M B Allen, S V Vathenen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 2009
Response on behalf of the UK Stereotactic Body Radiotherapy Consortium to Brock et al. Clin Oncol (R Coll Radiol) 2008;20(9):666-676K N Franks, P Jain, M Dahele, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 3, 2008
Epirubicin/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual functionJ M Zekri, L M El-Helw, O P Purohit, et al.
The British Journal of Radiology|July 23, 2013
Stereotactic ablative radiotherapy in the UK: current status and developmentsP Jain, A Baker, G Distefano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2001
The impact of virtual simulation in palliative radiotherapy for non-small-cell lung cancerM McJury, P M Fisher, S Pledge, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
Carboplatin, 5-fluorouracil and folinic acid: a 48-hour chemotherapy regimen in advanced and recurrent squamous carcinoma of the head and neckM Q Hatton, E J Junor, J Paul, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 11, 2004
The management and survival of patients with advanced germ-cell tumours: improving outcome in intermediate and poor prognosis patientsN Bhala, J M Coleman, C R Radstone, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 24, 2009
Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvementJ D Fenwick, A E Nahum, Z I Malik, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 30, 2010
Review of testing and use of adjuvant trastuzumab across a cancer network--are we treating the right patients?S G Coulson, V S Kumar, I M Manifold, et al.
BMJ Supportive & Palliative Care|May 3, 2014
Quality of life, support and smoking in advanced lung cancer patients: a qualitative studyC Rowland, S J Danson, R Rowe, et al.
Pageof 4